Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
about
Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in MiceCardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.Doxorubicin induced heart failure: Phenotype and molecular mechanisms.Mitoxantrone, More than Just Another Topoisomerase II Poison.Oxidative stress does not play a primary role in the toxicity induced with clinical doses of doxorubicin in myocardial H9c2 cells.Current views on anthracycline cardiotoxicity.Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant.Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles.Aspalathin Reverts Doxorubicin-Induced Cardiotoxicity through Increased Autophagy and Decreased Expression of p53/mTOR/p62 Signaling.The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.Cardiovascular complications of multiple myeloma in the elderly.Molecular Mechanisms of the Cardiotoxicity of the Proteasomal-Targeted Drugs Bortezomib and Carfilzomib.Topoisomerases as anticancer targets.Creatine Supplementation and Doxorubicin-Induced Skeletal Muscle Dysfunction: An Ex Vivo Investigation.
P2860
Q27345163-37A82889-83CC-4044-865A-19B34F7778ABQ36153375-E159232A-9422-44A3-A4F8-F4F976FC4579Q36912561-DFAC9F67-BE84-4FED-B3A4-48C448271FD0Q38569206-0BE7AEF4-3C59-429F-BD13-0BEFD14BA3FBQ38797529-D7F397F8-3A3A-4978-8A6C-54A4D7A9CCB2Q38845535-EDC1C8C8-6D3F-47A8-B374-E96D324CC997Q39264180-A9D9EBB4-2BE9-4685-8A10-19ECB0A63C3CQ39270177-FE990051-D3F0-477A-9E7E-6AD02B694348Q41532042-905EB970-422B-465A-83E2-EF5911E40461Q46309786-F748C3EE-965A-4896-BD8F-2FB2A670E334Q47339443-0616B14E-AEC5-4BDD-AD3B-402CCACB0676Q47374630-59BB84B3-4405-4680-86D9-B3F98F032F71Q48170012-C36B6BB1-469A-4655-AC49-8C2152C04FFBQ49832269-41B14A06-4B2A-44A5-814B-8EFB34183211Q50785546-6C0F14E5-F653-419D-9452-FF1BD9DE581B
P2860
Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Dexrazoxane may prevent doxoru ...... oth topoisomerase II isoforms.
@ast
Dexrazoxane may prevent doxoru ...... oth topoisomerase II isoforms.
@en
Dexrazoxane may prevent doxoru ...... oth topoisomerase II isoforms.
@nl
type
label
Dexrazoxane may prevent doxoru ...... oth topoisomerase II isoforms.
@ast
Dexrazoxane may prevent doxoru ...... oth topoisomerase II isoforms.
@en
Dexrazoxane may prevent doxoru ...... oth topoisomerase II isoforms.
@nl
prefLabel
Dexrazoxane may prevent doxoru ...... oth topoisomerase II isoforms.
@ast
Dexrazoxane may prevent doxoru ...... oth topoisomerase II isoforms.
@en
Dexrazoxane may prevent doxoru ...... oth topoisomerase II isoforms.
@nl
P2093
P2860
P356
P1433
P1476
Dexrazoxane may prevent doxoru ...... oth topoisomerase II isoforms.
@en
P2093
Andrea Nemecek
Cathleen Jendrny
Leszek Wojnowski
Mladen Vincetic
Shiwei Deng
Tiandong Yan
Ute Gödtel-Armbrust
P2860
P2888
P356
10.1186/1471-2407-14-842
P407
P577
2014-11-18T00:00:00Z
P5875
P6179
1042024497